Former OpenAI Science Head Launches Warp Sciences to Automate Lab Work with Robots

At a glance

Kevin Weil, former chief science officer at OpenAI, has founded Warp Sciences, an AI startup that automates lab work for drug development. The company teaches robots to make and test promising compounds chosen by researchers. It has reportedly raised $215 million at a valuation of $865 million.

Key points

1. 1

   Robots take on the work of making and testing substances directly in the lab.

2. 2

   Until now, many biotech companies have outsourced molecule synthesis to outside vendors, including ones in China.

3. 3

   Weil aims to bring this work back in-house to reduce supply chain risks.

4. 4

   Human chemists wear camera and sensor gloves to teach the robots their tasks.

Why it matters

Drug development is slow and expensive, so automating lab work could speed it up, which makes this important.